Literatur
Westphal, O., Lüderitz, O., Galanos, C., Mayer, H., Rietschel, E. Th. The story of bacterial endotoxin. Adv. Immunopharmocol. In: (Chedid, L, Hadden, J. W., Ipreafico, F., Dukor, P., Willoghby, D. [eds.]) 3 (1986) pp. 13–34.
Lüderitz, O., Freudenberg, M. A., Galanos, C., Lehmann, V., Rietschel, E. Th., Shaw, D. H. Lipopolysaccharides of gram-negative bacteria. In:Razin, S., Rottem, S. (eds.): Membrane lipids of prokaryotes. Current topics in membranes and transport. Academic Press Inc., New York 1982, pp. 79–151.
Johnston, C. A., Greisman, S. E. Endotoxemia induced by antibiotic therapy: A mechanism for adrenal corticosteroid protection in gram-negative sepsis. Trans. Ass. Amer. Physcns. 97 (1984) 172–181.
Galanos, C., Lüderitz, O., Rietschel, E. Th., Westphal, O. Neweraspects of the chemistry and biology of bacterial lipopolysaccharides, with special reference to their lipid A component. In:Goodwin, T. W. (ed.): International review of biochemistry, Biochemistry of lipids II. University Park Press, Baltimore, Vol. 14, 1977, pp. 239–335.
Jann, K., Jann, B. Structure and biosynthesis of O-antigens. In:Proctor, R. A. (ed): Handbook of Endotoxin, Vol. I.Rietschel, E. Th. (ed.): Chemistry of Endotoxin. Elsevier, Amsterdam, New York, Oxford 1984, pp. 138–186.
Tacken, A., Rietschel, E. Th., Brade, H. Methylation analysis of the heptose / 3-deoxy-D-manno-2-octulosonic acid region (inner core) of lipopolysaccharide fromSalmonella minnesota rough mutants. Carb. Res. 149 (1986) 279–291.
Rietschel, E. Th., Wollenweber, H. W., Brade, H., Zähringer, U., Lindner, B., Seydel, U., Bradaczek, H., Barnickel, G., Labischinski, H., Giesbrecht, P. Structure and conformation of the lipid A component of lipopolysaccharides. in:Proctor, R. A. (ed.) Handbook of endotoxin, Vol. 1,Rietschel, E. Th. (ed.) Chemistry of endotoxin. Elsevier, Amsterdam, New York, Oxford 1984, pp. 187–220.
Zähringer, U., Lindner, B., Seydel, U. Rietschel, E. Th., Naoki, H., Unger, F. M., Imoto, M., Kusumoto, S., Shiba, T. Structure of de-O-acylated lipopolysaccharide from theEscherichia coli Re mutant F 515. Tetrahedron Lett. 26 (1985) 6321–6324.
Westphal, O., Lüderitz, O. Chemische Erforschung von Lipopolysacchariden gramnegativer Bakterien. Angew. Chem. 66 (1954) 407–417.
Imoto, M., Yoshimura, H., Sakaguchi, N., Kusumoto, S., Shiba, T. Total synthesis ofEscherichia coli lipid A. Tetrahedron Lett. 26 (1985) 1545–1548.
Galanos, C., Lüderitz, O., Rietschel, E. Th., Westphal, O., Brade, H., Brade, L., Freudenberg, M. A., Schade, U., Imoto, M., Yoshimura, H., Kusumoto, S., Shiba, T. Synthetic and naturalEscherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 148 (1985) 1–5.
Kotani, S., Takada, H., Tsujimoto, M., Ogawa, T., Takahashi, I., Ideka, T., Otsuka, K., Shimanchi, H., Kasai, N., Mashimo, J., Nagao, S., Tanaka, S., Harada, K., Nagaki, K., Kitamura, H., Shiba, T., Kusumoto, S., Imoto, M., Yoshimura, H. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from anEscherichia coli Re-mutant. Infect. Immun. 49 (1985) 225–237.
Homma, J. Y., Matsuura, M., Kanegasaki, S., Kawakubo, Y., Kojima, Y., Shibukawa, N., Kumazawa, Y., Yamamoto, A., Tanamoto, K., Yasuda, T., Imoto, M., Yoshimura, H., Kusumoto, S., Shiba, T. Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J. Biochem. (Tokyo) 98 (1985) 395–406.
Loppnow, H., Brade, L., Brade, H., Rietschel, E. Th., Kusumoto, S., Shiba, T., Flad, H.-D. Lipid A-induced production of interleukin 1 in human monocytes. Eur. J. Immunol. 16 (1986) 1263–1267.
Rietschel, E. Th., Brade, H., Brade, L., Brandenburg, K., Schade, U., Seydel, U., Zähringer, U., Galanos, C., Lüderitz, O., Westphal, O., Labischinski, H., Kusumoto, S., Shiba, T. Lipid A, the endotoxic center of bacterial lipopolysaccharide: relation of chemical structure to biological activity. In:Watson, S. (ed.): 2nd International Conference on endotoxins and Their Detection with theLimulus amebocyte lysate. Alan R. Liss Inc., New York 1986 (im Druck).
Brandenburg, K., Seydel, U. Physical aspects of structure and function of membranes made from lipopolysaccharides and free lipid A. Biochem. Biophys. Acta 775 (1984) 225–238.
Labischinski, H., Barnickel, G., Bradaczek, H., Naumann, D., Rietschel, E. Th., Giesbrecht, P. High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J. Bacteriol. 162 (1985) 9–20.
Lindberg, A. A., Wollin, R., Bruse, C., Ekwall, E., Svensson, S. B.: Immunology and immunochemistry of synthetic and semisyntheticSalmonella O-antigen-specific glyco-conjugates. In:Anderson, L., Unger, F. (eds.) Bacterial Lipopolysaccharides: Structure, synthesis, biological activities. Am. Chem. Soc. Symp. Series 231, 1983, Washington D. C., pp. 195–218.
van Dijk, W. C., Verbrug, H. A., van Erne-van der Tol, M. E., Peters, R., Verhoef, J. Escherichia coli antibodies in opsonistation and protection against infection. J. Med. Microbiol. 14 (1981) 381–389.
Lindberg, A. A., Greisman, S. E., Svensson, S. B. Induction of endotoxin tolerance with nonpyrogenic O-antigenic oligosaccharideprotein conjugates. Infect. Immun. 41 (1983) 888–895.
Johnston, C. A., Greisman, S. E. Mechanisms of endotoxin tolerance. In:Proctor, R. A. (ed.): Handbook of endotoxin, Vol. 2,Hinshaw, L. B. (ed.): Pathophysiology of endotoxin. Elsevier, Amsterdam, New York, Oxford 1985, pp. 359–401.
Collins, M. S., Roby, R. E. Protective activity of an intravenous immunoglobulin (human) enriched in antibody against lipopolysaccharide antigens ofPseudomonas aeruginosa. Am. J. Med. 76 (1984) 168–176.
Gaffin, S. L. Gram-negative bacteraemia: New therapeutic possibilities with anti-endotoxin antibodies. Haemet. Blood Trans. 29 (1985) 107–111.
Pennington, J. E., Pier, C. B., Small, G. J. Efficacy of intravenous immunoglobulin for treatment of experimentalPseudomonas aeruginosa infection. J. Crit. Care 1 (1986) 4–12.
Brade, L., Kosma, P., Appelmelk, B. J., Paulsen, H., Brade, H.: Determination of the epitope specificity of monoclonal antibodies against the 3-deoxy-D-manno-2-octulosonate region of bacterial lipopolysaccharide by use of synthetic antigens. Infect. Immun. 1986 (im Druck).
Ziegler, E. J., Douglas, H., Sherman, J. E., Davis, C. E., Braude, A. I. Treatment ofE. coli andKlebsiella bacteremia in agranulocytic animals with antiserum to a UDP-GAL epimerasedeficient mutant. J. Immunol. 111 (1973) 433–438.
Johns, M., Skehill, A., McCabe, W. R. Immunization with rough mutants ofSalmonella minnesota IV. Protection by antisera to O and rough antigens against endotoxin. J. Inf. Dis. 147 (1983) 57–67.
Trautmann, M., Hahn, H. Antiserum againstEscherichia coli J5: A reevaluation of itsin vitro andin vivo activity against heterologous gram-negative bacteria. Infection 13 (1985) 140–145.
Siber, G. R., Kania, S. A., Warren, H. S. Cross-reactivity of rabbit antibodies to lipopolysaccharides ofEscherichia coli J5 and other gram-negative bacteria. J. Infect. Dis. 152 (1985) 954–964.
Brade, H., Galanos, C. Common lipopolysaccharide specificity: new type of antigen residing in the inner core region of S- and R- form lipopolysacharides from different families of gram-negative bacteria. Infect. Immun. 42 (1983) 250–256.
Brade, L., Brade, H. A 28,000 Dalton protein of normal mouse serum binds specifically to the inner core region of bacterial lipopoly-saccharide. Infect. Immun. 50 (1985) 687–694.
Kim, Y. B., Watson, D. W. Modification of host response to bacterial endotoxins. II. Passive transfer of immunity to bacterial endotoxin with fractions containing 19S antibodies. J. Exp. Med. 121 (1965) 751–759.
Galanos, C., Lüderitz, O., Westphal, O. Preparation and properties of antisera against the lipid A component of bacterial lipopolysaccharides. Eur. J. Biochem. 24 (1971) 116–122.
Galanos, C., Freudenberg, M. A., Jay, F., Nerkar, D., Veleva, K., Brade, H., Strittmatter, W. Immunogenic properties of lipid A. Rev. Infect Dis. 5 (1984) 546–552.
Jirillo, E., Miragliotta, G., Galanos, C., Rietschel, E. Th., Michalek, S. M., McGhee, J. R. (eds.): Endotoxin: structural aspects and immunobiology of host responsese. EOS — Riv. Immunol. Immunofarm. 6 Suppl. (1986) 1–275.
Marget, W., Mar, P. J., Jaspers, L. Preliminary study on administration of high-titer lipid A antibody serum in sepsis and septic shock patients. Infection 13 (1985) 120–125.
Brade, L., Brade, H. Characterization of two different antibodies recognizing two distinct antigenic determinants in free lipid A ofEscherichia coli. Infect. Immun. 48 (1985) 569–575.
Brade, L., Rietschel, E. Th., Kusumoto, S., Shiba, T., Brade, H. Immunogenicity and antigenicity of syntheticEscherichia coli lipid A. Infect. Immun. 51 (1986) 110–114.
Kusumoto, S., Yoshimura, H., Imoto, M., Shimamoto, T., Shiba, T. Chemical synthesis of 1-dephospho derivatives ofEscherichia coli lipid A. Tetrahedron Lett. 26 (1985) 909–912.
Galanos, C., Lehmann, V., Lüderitz, O., Rietschel, E. Th., Westphal, O., Brade, H., Brade, L., Freudenberg, M. A., Hansen-Hagge, T., Lüderitz, Th., McKenzie, G., Schade, U., Strittmatter, W., Tanamoto, K., Zähringer, U., Imoto, M., Yoshimura, H., Yamamoto, M., Shimamoto, T., Kusumoto, S., Shiba, T. Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur. J. Biochem. 140 (1984) 221–227.
Brade, L., Rietschel, E. Th., Kusumoto, S., Shiba, T., Brade, H. Immunogenicity and antigenicity of natural and syntheticEscherichia coli lipid A and derivatives thereof. In:Watson, S. W. (ed.): 2nd International Conference on Endotoxins and Their Detection with theLimulus amoebocyte lysate test. Alan R. Liss Inc., New York 1986 (im Druck).
Freudenberg, M. A., Keppler, D., Galanos, C. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization of endotoxin. Infect. Immun. 51 (1986) 891–895.
Schade, U., Rietschel, E. Th. The role of prostaglandins in endotoxic activities. Klin. Wochenschr. 60 (1982) 743–745.
Hagman, W., Denzlinger, C., Keppler, D. Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action. Circ. Shock 14 (1984) 223–235.
Lüderitz, Th., Schade, U., Rietschel, E. Th. Formation and metabolism of leukotriene C4 in macrophages exposed to bacterial lipopolysaccharide. Eur. J. Biochem. 155 (1986) 377–382.
Beutler, B., Milsark, I. W., Cerami, A. C. Passive immunization against cachectin/tumour necrosis factor protects mice from lethal effect of endotoxin. Science 229 (1985) 869–871.
Freudenberg, M., Galanos, C. Alteration in ratsin vivo of the chemical structure of lipopolysaccharides fromSalmonella abortus equi. Eur. J. Biochem. 152 (1985) 353–359.
Munford, R. S. Deacylation of bacterial endotoxins by neutrophils and macrophages: early observations and hypotheses. Meth. and Find. Exptl. Clin. Pharmacol. 8 (1986) 63–65.
Ray, P. H., Kelsey, J. E., Bigham, E. C., Benedict, C. D., Miller, T. A.: Synthesis and use of 3-deoxy-D-manno-2-octulosonate (KDO) inEscherichia coli. Potential sites of inhibition. In:Anderson, L., Unger, F. M. (eds.) Bacterial Lipopolysaccharides: Structure, synthesis and biological activities. Am. Chem. Soc. Symp. Series 231 (1983) Washington, D. C., pp. 141–169.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rietschel, E.T., Brade, H. Lipopolysaccharide, die Endotoxine und O-Antigene gramnegativer Bakterien: Chemische Struktur, biologische Wirkung und serologische Eigenschaften. Infection 15 (Suppl 2), S76–S84 (1987). https://doi.org/10.1007/BF01644198
Issue Date:
DOI: https://doi.org/10.1007/BF01644198